Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,624 across all filing types
Latest filing 2023-04-27 Report Publication Anno…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
Notification Letter and Request Form to Non-registered holders - Notice of Publication of Annual Report and Annual General Meeting Circular ("Current Corporate Communications")
Report Publication Announcement Classification · 100% confidence The document is a notification letter from RemeGen Co., Ltd. informing non-registered shareholders about the publication of the Annual Report and Annual General Meeting Circular. It provides instructions on how to access the reports online and how to request printed versions. The document does not contain the actual annual report or AGM materials but serves as a notice of their availability. The document length is 6888 characters, which is relatively short and consistent with a notification letter rather than a full report. Therefore, according to the 'Menu vs Meal' rule, this document is an announcement regarding the publication of reports, not the reports themselves.
2023-04-27 English
2022 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2022' for RemeGen Co., Ltd. It contains detailed sections typical of an annual report, including corporate information, chairman's statement, management discussion and analysis, biographies of directors and senior management, corporate governance report, directors' report, independent auditor's report, consolidated financial statements, notes to financial statements, and financial summary. The length is substantial (15,000 characters), indicating a full report rather than a brief announcement. The content includes comprehensive financial and operational details for the fiscal year ended December 31, 2022, consistent with an official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-04-27 English
2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information Classification · 100% confidence The document is titled '2022 Environmental, Social and Governance Report' for RemeGen Co., Ltd. It covers the reporting period January 1 to December 31, 2022, and includes detailed sections on sustainability, governance, environmental protection, employee and community engagement, and other ESG-related topics. The content aligns with ESG reporting standards such as the Hong Kong Stock Exchange ESG Guide and the Global Reporting Initiative. There is no indication that this is an announcement or a brief summary; rather, it is a comprehensive report on ESG performance. Therefore, the document fits the category of Environmental & Social Information (SR).
2023-04-27 English
2022 ANNUAL GENERAL MEETING CIRCULAR
AGM Information Classification · 100% confidence The document is a circular for the 2022 Annual General Meeting (AGM) of RemeGen Co., Ltd. It includes detailed information about the agenda items to be discussed and voted on at the AGM, such as the 2022 reports on the work of the Board of Directors and Supervisory Committee, the 2022 Financial Accounts Report, the 2022 Annual Report and Accounts, profit distribution plan, re-appointment of auditors, remuneration of directors and supervisors, and election of directors. It also contains the notice of the AGM, proxy form instructions, and biographies of director candidates. The document is comprehensive and intended to inform shareholders for voting purposes at the AGM. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting. The document is not the annual report itself, nor is it a simple announcement or regulatory filing. It is a detailed circular for the AGM, which is a classic example of AGM Information.
2023-04-27 English
NOTICE OF 2022 ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice for the 2022 Annual General Meeting (AGM) of RemeGen Co., Ltd. It includes details about the meeting date, location, agenda items such as approval of the annual report, election of directors, and other shareholder resolutions. The text explicitly states it is a "NOTICE OF 2022 ANNUAL GENERAL MEETING" and contains no actual financial statements or detailed financial data, only the agenda and procedural information for the AGM. The document length is 7338 characters, which is consistent with a detailed notice but not a full report. Therefore, this document is best classified as AGM Information (AGM-R).
2023-04-27 English
PROXY FORM FOR USE AT THE 2022 ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a proxy form for the 2022 Annual General Meeting (AGM) of RemeGen Co., Ltd. It includes instructions for shareholders to appoint proxies to vote on various resolutions at the AGM, including approval of the annual report, financial accounts, election of directors, and other corporate matters. The content is focused on voting procedures and proxy appointments rather than the actual annual report or financial statements. This type of document is typically classified as AGM Information, as it is material shared for the AGM to facilitate shareholder voting and participation.
2023-04-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.